Solid state interactions between the proton pump inhibitor omeprazole and various enteric coating polymers.

The influence of the acidic film formers Eudragit L 100, HPMCAS-HF, HP-55, and shellac on the stability of the acid-labile proton pump inhibitor omeprazole in solid drug-polymer blends at accelerated storage conditions (40 degrees C/75% RH) was determined by fourier transform infrared spectroscopy (FTIR), modulated temperature differential scanning calorimetry (MTDSC), and high performance liquid chromatography (HPLC). As expected, acidic polymers caused a degradation of omeprazole which was manifested by discolorations and increasing amounts of degradation products. However, MTDSC curves and FTIR spectra did not show additional peaks resulting from the omeprazole degradation products. These methods appeared to be not sensitive enough to separate analytically the drug and polymer signals from those of the decomposition products. With HPLC a sufficient quantification of the degradation products was possible. HP-55 caused the highest degree of omeprazole degradation, followed by shellac, HPMCAS-HF, and Eudragit L 100. No correlation with the microenvironmental pH values generated by the acidic polymers at the applied storage conditions was found. The melting process and the dissolution of acidic impurities were figured out as possible reasons for the more pronounced decomposition of the drug in presence of HP-55 and shellac.

[1]  S. Hoag,et al.  Influence of various drugs on the glass transition temperature of poly(vinylpyrrolidone): a thermodynamic and spectroscopic investigation. , 2001, International journal of pharmaceutics.

[2]  T. Jacobsen,et al.  Effect of various salts on the stability of lansoprazole, omeprazole, and pantoprazole as determined by high-performance liquid chromatography. , 1999, Drug development and industrial pharmacy.

[3]  C. Leopold,et al.  Quantification of omeprazole degradation by enteric coating polymers: an UV-VIS spectroscopy study. , 2005, Die Pharmazie.

[4]  A. Pilbrant,et al.  Development of an oral formulation of omeprazole. , 1985, Scandinavian journal of gastroenterology. Supplement.

[5]  F. Giordano,et al.  Study of Omeprazole-γ-Cyclodextrin Complexation in the Solid State , 2000 .

[6]  J. Yliruusi,et al.  Amylopectin as a subcoating material improves the acidic resistance of enteric-coated pellets containing a freely soluble drug. , 2002, International journal of pharmaceutics.

[7]  P. Lindberg,et al.  Chemical Reactions of Omeprazole and Omeprazole Analogues. VI. The Reactions of Omeprazole in the Absence of 2-Mercaptoethanol. , 1989 .

[8]  K. E. Schwartz,et al.  In vivo and in vitro evaluation of four different aqueous polymeric dispersions for producing an enteric coated tablet , 1995 .

[9]  T. Beckert,et al.  Investigation of Potential Ionic Interactions Between Anionic and Cationic Polymethacrylates of Multiple Coatings of Novel Colonic Delivery System , 2002, Drug development and industrial pharmacy.

[10]  Tanja Schmidt-Mende.  Freisetzung aus magensaftresistent überzogenen Arzneiformen , 2001 .

[11]  A. G. Davidson,et al.  A Survey of the Stability of Omeprazole Products from 13 Countries , 1996 .

[12]  C. Leopold,et al.  Degradation of Omeprazole Induced by Enteric Polymer Solutions and Aqueous Dispersions: HPLC Investigations , 2005, Drug development and industrial pharmacy.

[13]  P. Lindberg,et al.  Chemical Reactions of Omeprazole and Omeprazole Analogues. I. A Survey of the Chemical Transformations of Omeprazole and its Analogues. , 1989 .

[14]  J. Siepmann,et al.  Pharmaceutical Applications of Shellac: Moisture-Protective and Taste-Masking Coatings and Extended-Release Matrix Tablets , 2003, Drug development and industrial pharmacy.

[15]  R. Bodmeier,et al.  Dry polymer powder coating and comparison with conventional liquid-based coatings for Eudragit) RS, ethylcellulose and shellac. , 2003, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[16]  T. Govender,et al.  Drug Release and Surface Morphology Studies on Salbutamol Controlled Release Pellets , 1995 .

[17]  V. Gallardo,et al.  Determination of the stability of omeprazole by means of differential scanning calorimetry , 1998 .

[18]  T. Makino,et al.  Stabilization of a new antiulcer drug (Lansoprazole) in the solid dosage forms , 1992 .

[19]  K. Lehmann.  CHEMISTRY AND APPLICATION PROPERTIES OF POLYMETHACRYLATE COATING SYSTEMS , 1997 .

[20]  V. D. Gupta,et al.  Stability of Omeprazole Solutions at Various ph Values as Determined by High-Performance Liquid Chromatography , 1995 .

[21]  J. Senn‐Bilfinger,et al.  (H+-K+)-ATPase inhibiting 2-[(2-pyridylmethyl)sulfinyl]benzimidazoles. 2. The reaction cascade induced by treatment with acids. Formation of 5H-pyrido[1',2':4,5][1,2,4]thiadiazino[2,3-a]benzimidazol-13-ium salts and their reactions with thiols , 1987 .

[22]  L. Thomas,et al.  A discussion of the principles and applications of Modulated Temperature DSC (MTDSC). , 1999, International journal of pharmaceutics.

[23]  D. Rodrigues,et al.  In vitro evaluation of dissolution properties and degradation products of omeprazole in enteric-coated pellets. , 1998, Drug development and industrial pharmacy.